
-
'Resilient' Warriors aim to close out Rockets in bruising NBA playoff series
-
US expects Iran talks but Trump presses sanctions
-
Baffert returns to Kentucky Derby, Journalism clear favorite
-
Top Trump security official replaced after chat group scandal
-
Masked protesters attack Socialists at France May Day rally
-
Mumbai eliminate Rajasthan from IPL playoff race with bruising win
-
McDonald's profits hit by weakness in US market
-
Rio goes Gaga for US singer ahead of free concert
-
New research reveals where N. American bird populations are crashing
-
Verstappen late to Miami GP as awaits birth of child
-
Zelensky says minerals deal with US 'truly equal'
-
Weinstein lawyer says accuser sought payday from complaint
-
Police arrest more than 400 in Istanbul May Day showdown
-
Herbert named head coach of Canada men's basketball team
-
'Boss Baby' Suryavanshi falls to second-ball duck in IPL
-
Shibutani siblings return to ice dance after seven years
-
300,000 rally across France for May 1, union says
-
US-Ukraine minerals deal: what we know
-
Top Trump official ousted after chat group scandal: reports
-
Schueller hat-trick sends Bayern women to first double
-
Baudin in yellow on Tour de Romandie as Fortunato takes 2nd stage
-
UK records hottest ever May Day
-
GM cuts 2025 outlook, projects up to $5 bn hit from tariffs
-
Thousands of UK children write to WWII veterans ahead of VE Day
-
Top Trump official exiting after chat group scandal: reports
-
Madrid Open holder Swiatek thrashed by Gauff in semis
-
Sheinbaum says agreed with Trump to 'improve' US-Mexico trade balance
-
US veteran convicted of quadruple murder to be executed in Florida
-
UK counter terrorism police probe Irish rappers Kneecap
-
S. Korea crisis deepens with election frontrunner retrial, resignations
-
Trump administration releases report critical of youth gender care
-
IKEA opens new London city centre store
-
Police deploy in force for May Day in Istanbul, arrest hundreds
-
Syria Druze leader condemns 'genocidal campaign' against community
-
Prince Harry to hear outcome of UK security appeal on Friday
-
Microsoft raises Xbox prices globally, following Sony
-
US stocks rise on Meta, Microsoft ahead of key labor data
-
Toulouse injuries mount as Ramos doubtful for Champions Cup semi
-
Guardiola glad of Rodri return but uncertain if he'll play in FA Cup final
-
Ruud sails past Medvedev into Madrid Open semis
-
'Not a commodity': UN staff rally over deep cuts
-
Flintoff proud as Afghan refugee protege plays for Lancashire second team
-
Peruvian cardinal accused of abuse challenges late pope's sanction
-
Trans women barred from women's football by English, Scottish FAs
-
Oil prices drop, stocks diverge amid economic growth fears
-
Israel brings fire near Jerusalem 'under control', reopens roads
-
Lopetegui appointed coach of Qatar
-
UK counter-terrorism unit probes rappers Kneecap but music stars back band
-
Yamal heroics preserve Barca Champions League final dream
-
2026 T20 World Cup 'biggest women's cricket event in England' - ECB

Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
C.Garcia--AMWN